Zheng, Z.N. (2026) “Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates”, World Journal of Oncology, 17(2), pp. 129–142. doi:10.14740/wjon2718.